Home » Analyst Articles – US

Image for AltaGas (OTCMKTS:ATGFF) Given New C$34.00 Price Target at Royal Bank of Canada

AltaGas (OTCMKTS:ATGFF) Given New C$34.00 Price Target at Royal Bank of Canada

AltaGas (OTCMKTS:ATGFF – Get Rating) had its price objective raised by Royal Bank of Canada from C$33.00 to C$34.00 in a research note released on Friday morning, The Fly reports. A number of other equities research analysts... More of this article »
Image for Auto Trader Group (OTCMKTS:ATDRY) Upgraded to Neutral at JPMorgan Chase & Co.

Auto Trader Group (OTCMKTS:ATDRY) Upgraded to Neutral at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of Auto Trader Group (OTCMKTS:ATDRY – Get Rating) from an underweight rating to a neutral rating in a research report sent to investors on Friday, The Fly reports. ATDRY has been the... More of this article »
Image for Deliveroo (OTCMKTS:DROOF) Downgraded to “Neutral” at JPMorgan Chase & Co.

Deliveroo (OTCMKTS:DROOF) Downgraded to “Neutral” at JPMorgan Chase & Co.

JPMorgan Chase & Co. downgraded shares of Deliveroo (OTCMKTS:DROOF – Get Rating) from an overweight rating to a neutral rating in a report issued on Friday morning, The Fly reports. DROOF has been the subject of a number... More of this article »
Image for Legrand (OTCMKTS:LGRVF) Downgraded by Zacks Investment Research

Legrand (OTCMKTS:LGRVF) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of Legrand (OTCMKTS:LGRVF – Get Rating) from a hold rating to a sell rating in a research note released on Friday morning, Zacks.com reports. According to Zacks, “Legrand SA provides... More of this article »
Image for Shiseido (OTCMKTS:SSDOY) Lowered to “Strong Sell” at Zacks Investment Research

Shiseido (OTCMKTS:SSDOY) Lowered to “Strong Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Shiseido (OTCMKTS:SSDOY – Get Rating) from a hold rating to a strong sell rating in a research report sent to investors on Friday, Zacks.com reports. According to Zacks, “SHISEIDO... More of this article »
Image for Ülker Bisküvi Sanayi A.S. (OTCMKTS:UELKY) Price Target Lowered to 25.20 at JPMorgan Chase & Co.

Ülker Bisküvi Sanayi A.S. (OTCMKTS:UELKY) Price Target Lowered to 25.20 at JPMorgan Chase & Co.

Ülker Bisküvi Sanayi A.S. (OTCMKTS:UELKY – Get Rating) had its price objective decreased by JPMorgan Chase & Co. from 25.70 to 25.20 in a research report report published on Friday morning, The Fly reports. JPMorgan Chase... More of this article »
Image for JPMorgan Chase & Co. Downgrades Schibsted ASA (OTCMKTS:SBBTF) to Underweight

JPMorgan Chase & Co. Downgrades Schibsted ASA (OTCMKTS:SBBTF) to Underweight

JPMorgan Chase & Co. cut shares of Schibsted ASA (OTCMKTS:SBBTF – Get Rating) from a neutral rating to an underweight rating in a research note published on Friday morning, The Fly reports. Several other research analysts... More of this article »
Image for Hawkins (NASDAQ:HWKN) Upgraded to “Buy” at Zacks Investment Research

Hawkins (NASDAQ:HWKN) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Hawkins (NASDAQ:HWKN – Get Rating) from a hold rating to a buy rating in a research report released on Friday morning, Zacks.com reports. Zacks Investment Research currently has $40.00... More of this article »
Image for Derwent London (OTCMKTS:DWVYF) Upgraded to “Hold” by Zacks Investment Research

Derwent London (OTCMKTS:DWVYF) Upgraded to “Hold” by Zacks Investment Research

Zacks Investment Research upgraded shares of Derwent London (OTCMKTS:DWVYF – Get Rating) from a sell rating to a hold rating in a report released on Friday, Zacks.com reports. According to Zacks, “Derwent London plc is... More of this article »
Image for Inozyme Pharma (NASDAQ:INZY) Downgraded by Zacks Investment Research to Hold

Inozyme Pharma (NASDAQ:INZY) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research downgraded shares of Inozyme Pharma (NASDAQ:INZY – Get Rating) from a buy rating to a hold rating in a research report report published on Friday morning, Zacks.com reports. According to Zacks, “Inozyme... More of this article »
Image for Capri (NYSE:CPRI) Rating Lowered to Hold at StockNews.com

Capri (NYSE:CPRI) Rating Lowered to Hold at StockNews.com

StockNews.com cut shares of Capri (NYSE:CPRI – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Friday morning. Other research analysts also recently issued research reports about the stock.... More of this article »
Image for Kazia Therapeutics (NASDAQ:KZIA) Upgraded to Hold by Zacks Investment Research

Kazia Therapeutics (NASDAQ:KZIA) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of Kazia Therapeutics (NASDAQ:KZIA – Get Rating) from a sell rating to a hold rating in a report issued on Friday morning, Zacks.com reports. According to Zacks, “Kazia Therapeutics... More of this article »
Image for Adams Resources & Energy (NYSE:AE) Upgraded to “Strong-Buy” by StockNews.com

Adams Resources & Energy (NYSE:AE) Upgraded to “Strong-Buy” by StockNews.com

StockNews.com upgraded shares of Adams Resources & Energy (NYSE:AE – Get Rating) from a buy rating to a strong-buy rating in a report issued on Friday. NYSE AE opened at $34.49 on Friday. The company has a market cap of... More of this article »
Image for Logan Ridge Finance (NASDAQ:LRFC) Upgraded to Hold at Zacks Investment Research

Logan Ridge Finance (NASDAQ:LRFC) Upgraded to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Logan Ridge Finance (NASDAQ:LRFC – Get Rating) from a sell rating to a hold rating in a research report report published on Wednesday, Zacks.com reports. According to Zacks, “Logan... More of this article »
Image for Mirati Therapeutics (NASDAQ:MRTX) PT Lowered to $216.00 at The Goldman Sachs Group

Mirati Therapeutics (NASDAQ:MRTX) PT Lowered to $216.00 at The Goldman Sachs Group

Mirati Therapeutics (NASDAQ:MRTX – Get Rating) had its price target decreased by The Goldman Sachs Group from $253.00 to $216.00 in a research report report published on Tuesday, Stock Target Advisor reports. The Goldman Sachs... More of this article »
Image for Karuna Therapeutics (NASDAQ:KRTX) PT Lowered to $174.00 at The Goldman Sachs Group

Karuna Therapeutics (NASDAQ:KRTX) PT Lowered to $174.00 at The Goldman Sachs Group

Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its price objective cut by The Goldman Sachs Group from $202.00 to $174.00 in a research report sent to investors on Tuesday, Stock Target Advisor reports. They currently have... More of this article »
Image for Sage Therapeutics (NASDAQ:SAGE) Given New $73.00 Price Target at The Goldman Sachs Group

Sage Therapeutics (NASDAQ:SAGE) Given New $73.00 Price Target at The Goldman Sachs Group

Sage Therapeutics (NASDAQ:SAGE – Get Rating) had its price target decreased by The Goldman Sachs Group from $85.00 to $73.00 in a research report released on Tuesday morning, Stock Target Advisor reports. The Goldman Sachs Group... More of this article »
Image for Park-Ohio (NASDAQ:PKOH) Upgraded to Strong-Buy by Zacks Investment Research

Park-Ohio (NASDAQ:PKOH) Upgraded to Strong-Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Park-Ohio (NASDAQ:PKOH – Get Rating) from a hold rating to a strong-buy rating in a research note issued to investors on Tuesday morning, Zacks.com reports. The brokerage currently... More of this article »
Image for The Goldman Sachs Group Lowers Radius Health (NASDAQ:RDUS) Price Target to $8.00

The Goldman Sachs Group Lowers Radius Health (NASDAQ:RDUS) Price Target to $8.00

Radius Health (NASDAQ:RDUS – Get Rating) had its target price decreased by The Goldman Sachs Group from $9.00 to $8.00 in a research report sent to investors on Tuesday, Stock Target Advisor reports. The Goldman Sachs Group currently... More of this article »
Image for Tower Semiconductor (NASDAQ:TSEM) Upgraded to “Buy” by StockNews.com

Tower Semiconductor (NASDAQ:TSEM) Upgraded to “Buy” by StockNews.com

StockNews.com upgraded shares of Tower Semiconductor (NASDAQ:TSEM – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Friday morning. TSEM has been the subject of several other research... More of this article »
Image for Entravision Communications (NYSE:EVC) Upgraded to Buy by Zacks Investment Research

Entravision Communications (NYSE:EVC) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Entravision Communications (NYSE:EVC – Get Rating) from a hold rating to a buy rating in a research report report published on Friday, Zacks.com reports. Zacks Investment Research... More of this article »
Image for WestRock (NYSE:WRK) Lowered to “Buy” at StockNews.com

WestRock (NYSE:WRK) Lowered to “Buy” at StockNews.com

StockNews.com lowered shares of WestRock (NYSE:WRK – Get Rating) from a strong-buy rating to a buy rating in a report published on Friday. Several other equities analysts have also weighed in on the stock. KeyCorp reduced their... More of this article »
Image for Chimerix (NASDAQ:CMRX) Upgraded to Hold by StockNews.com

Chimerix (NASDAQ:CMRX) Upgraded to Hold by StockNews.com

StockNews.com upgraded shares of Chimerix (NASDAQ:CMRX – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Friday morning. Several other equities research analysts have also recently commented... More of this article »
Image for Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) Upgraded to Strong-Buy at StockNews.com

Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) Upgraded to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC – Get Rating) from a buy rating to a strong-buy rating in a research note published on Friday. Separately, JPMorgan Chase & Co. cut shares of Turkcell... More of this article »
Image for Zynerba Pharmaceuticals (NASDAQ:ZYNE) Upgraded by StockNews.com to Hold

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Upgraded by StockNews.com to Hold

StockNews.com upgraded shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) from a sell rating to a hold rating in a report released on Friday morning. Separately, Zacks Investment Research cut shares of Zynerba Pharmaceuticals... More of this article »
Image for Workday (NASDAQ:WDAY) Price Target Lowered to $220.00 at DA Davidson

Workday (NASDAQ:WDAY) Price Target Lowered to $220.00 at DA Davidson

Workday (NASDAQ:WDAY – Get Rating) had its target price cut by DA Davidson from $250.00 to $220.00 in a report published on Friday, The Fly reports. They currently have a buy rating on the software maker’s stock. Several... More of this article »
Image for Workday (NASDAQ:WDAY) Given New $230.00 Price Target at Piper Sandler

Workday (NASDAQ:WDAY) Given New $230.00 Price Target at Piper Sandler

Workday (NASDAQ:WDAY – Get Rating) had its target price cut by Piper Sandler from $360.00 to $230.00 in a research report sent to investors on Friday, The Fly reports. They currently have an overweight rating on the software... More of this article »
Image for Wynn Resorts (NASDAQ:WYNN) Lowered to Sell at Zacks Investment Research

Wynn Resorts (NASDAQ:WYNN) Lowered to Sell at Zacks Investment Research

Zacks Investment Research downgraded shares of Wynn Resorts (NASDAQ:WYNN – Get Rating) from a hold rating to a sell rating in a report released on Friday morning, Zacks.com reports. Zacks Investment Research currently has $68.00... More of this article »
Image for Deutsche Bank Aktiengesellschaft Cuts Workday (NASDAQ:WDAY) Price Target to $225.00

Deutsche Bank Aktiengesellschaft Cuts Workday (NASDAQ:WDAY) Price Target to $225.00

Workday (NASDAQ:WDAY – Get Rating) had its target price decreased by Deutsche Bank Aktiengesellschaft from $340.00 to $225.00 in a research note published on Friday morning, The Fly reports. WDAY has been the subject of several... More of this article »
Image for Dollar General (NYSE:DG) Price Target Cut to $234.00 by Analysts at Deutsche Bank Aktiengesellschaft

Dollar General (NYSE:DG) Price Target Cut to $234.00 by Analysts at Deutsche Bank Aktiengesellschaft

Dollar General (NYSE:DG – Get Rating) had its price target decreased by Deutsche Bank Aktiengesellschaft from $242.00 to $234.00 in a report published on Wednesday, The Fly reports. DG has been the subject of a number of other... More of this article »
Image for BRT Apartments (NYSE:BRT) Stock Rating Upgraded by Zacks Investment Research

BRT Apartments (NYSE:BRT) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of BRT Apartments (NYSE:BRT – Get Rating) from a hold rating to a strong-buy rating in a research report released on Tuesday morning, Zacks.com reports. Zacks Investment Research currently... More of this article »
Image for SentinelOne (NYSE:S) Cut to Sell at Zacks Investment Research

SentinelOne (NYSE:S) Cut to Sell at Zacks Investment Research

Zacks Investment Research cut shares of SentinelOne (NYSE:S – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According to Zacks, “SentinelOne... More of this article »
Image for Royal Bank of Canada Trims Advance Auto Parts (NYSE:AAP) Target Price to $217.00

Royal Bank of Canada Trims Advance Auto Parts (NYSE:AAP) Target Price to $217.00

Advance Auto Parts (NYSE:AAP – Get Rating) had its target price lowered by Royal Bank of Canada from $247.00 to $217.00 in a report released on Wednesday, The Fly reports. Other equities analysts have also recently issued research... More of this article »
Image for The Goldman Sachs Group Upgrades VNET Group (NASDAQ:VNET) to “Neutral”

The Goldman Sachs Group Upgrades VNET Group (NASDAQ:VNET) to “Neutral”

The Goldman Sachs Group upgraded shares of VNET Group (NASDAQ:VNET – Get Rating) from a sell rating to a neutral rating in a research report report published on Wednesday, MarketBeat reports. They currently have $6.50 price target... More of this article »
Image for Wells Fargo & Company Lowers WalkMe (NASDAQ:WKME) Price Target to $18.00

Wells Fargo & Company Lowers WalkMe (NASDAQ:WKME) Price Target to $18.00

WalkMe (NASDAQ:WKME – Get Rating) had its price objective cut by Wells Fargo & Company from $20.00 to $18.00 in a report released on Tuesday morning, Stock Target Advisor reports. They currently have an overweight rating... More of this article »
Image for J&J Snack Foods (NASDAQ:JJSF) Raised to Hold at Zacks Investment Research

J&J Snack Foods (NASDAQ:JJSF) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of J&J Snack Foods (NASDAQ:JJSF – Get Rating) from a strong sell rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “J&J... More of this article »
Image for Fossil Group (NASDAQ:FOSL) Rating Lowered to Hold at StockNews.com

Fossil Group (NASDAQ:FOSL) Rating Lowered to Hold at StockNews.com

StockNews.com cut shares of Fossil Group (NASDAQ:FOSL – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Tuesday. Shares of FOSL opened at $7.40 on Tuesday. Fossil Group has a 12-month... More of this article »
Image for Cardiff Oncology (NASDAQ:CRDF) Raised to “Hold” at Zacks Investment Research

Cardiff Oncology (NASDAQ:CRDF) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Cardiff Oncology (NASDAQ:CRDF – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday morning, Zacks.com reports. According to Zacks, “Cardiff... More of this article »
Image for CuriosityStream (NASDAQ:CURI) Rating Increased to Hold at Zacks Investment Research

CuriosityStream (NASDAQ:CURI) Rating Increased to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of CuriosityStream (NASDAQ:CURI – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, “CuriosityStream... More of this article »
Image for CollPlant Biotechnologies (NASDAQ:CLGN) Upgraded at Zacks Investment Research

CollPlant Biotechnologies (NASDAQ:CLGN) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of CollPlant Biotechnologies (NASDAQ:CLGN – Get Rating) from a strong sell rating to a hold rating in a research report released on Tuesday morning, Zacks.com reports. According to Zacks,... More of this article »
Image for CBTX (NASDAQ:CBTX) Rating Increased to Strong-Buy at Zacks Investment Research

CBTX (NASDAQ:CBTX) Rating Increased to Strong-Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of CBTX (NASDAQ:CBTX – Get Rating) from a hold rating to a strong-buy rating in a research note published on Tuesday morning, Zacks.com reports. The firm currently has $32.00 target price... More of this article »
Image for Origin Bancorp (NASDAQ:OBNK) Lifted to Buy at Zacks Investment Research

Origin Bancorp (NASDAQ:OBNK) Lifted to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Origin Bancorp (NASDAQ:OBNK – Get Rating) from a hold rating to a buy rating in a research note published on Wednesday morning, Zacks.com reports. The brokerage currently has $42.00... More of this article »
Image for Genius Sports (NYSE:GENI) PT Lowered to $9.00

Genius Sports (NYSE:GENI) PT Lowered to $9.00

Genius Sports (NYSE:GENI – Get Rating) had its price objective lowered by B. Riley from $13.00 to $9.00 in a research report report published on Wednesday morning, The Fly reports. B. Riley also issued estimates for Genius Sports’... More of this article »
Image for Laboratory Co. of America (NYSE:LH) PT Lowered to $300.00 at Morgan Stanley

Laboratory Co. of America (NYSE:LH) PT Lowered to $300.00 at Morgan Stanley

Laboratory Co. of America (NYSE:LH – Get Rating) had its price objective cut by Morgan Stanley from $360.00 to $300.00 in a research note issued to investors on Wednesday morning, Stock Target Advisor reports. They currently... More of this article »
Image for Truist Financial Cuts McDonald’s (NYSE:MCD) Price Target to $273.00

Truist Financial Cuts McDonald’s (NYSE:MCD) Price Target to $273.00

McDonald’s (NYSE:MCD – Get Rating) had its target price lowered by Truist Financial from $280.00 to $273.00 in a research note released on Wednesday morning, The Fly reports. The firm currently has a buy rating on the fast-food... More of this article »
Image for JPMorgan Chase & Co. (NYSE:JPM) Stock Rating Upgraded by Societe Generale

JPMorgan Chase & Co. (NYSE:JPM) Stock Rating Upgraded by Societe Generale

Societe Generale upgraded shares of JPMorgan Chase & Co. (NYSE:JPM) from a hold rating to a buy rating in a research report released on Tuesday morning, Marketbeat.com reports. They currently have $150.00 target price on the financial... More of this article »
Image for REE Automotive (NASDAQ:REE) Upgraded by Zacks Investment Research to “Buy”

REE Automotive (NASDAQ:REE) Upgraded by Zacks Investment Research to “Buy”

Zacks Investment Research upgraded shares of REE Automotive (NASDAQ:REE – Get Rating) from a hold rating to a buy rating in a research note released on Tuesday morning, Zacks.com reports. The brokerage currently has $1.75 target... More of this article »
Image for Gorman-Rupp (NYSE:GRC) Lifted to Strong-Buy at StockNews.com

Gorman-Rupp (NYSE:GRC) Lifted to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Gorman-Rupp (NYSE:GRC – Get Rating) from a buy rating to a strong-buy rating in a research report report published on Wednesday. Separately, Sidoti upgraded shares of Gorman-Rupp from a neutral... More of this article »
Image for StockNews.com Lowers North American Construction Group (NYSE:NOA) to Buy

StockNews.com Lowers North American Construction Group (NYSE:NOA) to Buy

StockNews.com lowered shares of North American Construction Group (NYSE:NOA – Get Rating) (TSE:NOA) from a strong-buy rating to a buy rating in a report published on Tuesday. A number of other analysts also recently weighed in... More of this article »
Image for Magellan Midstream Partners (NYSE:MMP) Upgraded at JPMorgan Chase & Co.

Magellan Midstream Partners (NYSE:MMP) Upgraded at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of Magellan Midstream Partners (NYSE:MMP – Get Rating) from a neutral rating to an overweight rating in a research note released on Wednesday, MarketBeat Ratings reports. JPMorgan Chase... More of this article »